Low Friction Bed Sheet

NCT ID: NCT01943201

Last Updated: 2016-11-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-01-31

Study Completion Date

2012-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Introduction:

It is known that people with spinal cord injury (SCI) bear a considerably increased risk of developing pressure ulcer, whereby frictional forces and shear forces are recognized as risk factors. It was the aim of the study to examine the effects of a specially developed low-friction hospital bed sheet on skin physiology as well as it's acceptance by patients with SCI.

Method:

Prospective, randomised crossover study. Patients with a subacute spinal cord injury will be recruited. Each patient spends five consecutive nights on the new, respectively, conventional bed sheet. After the five nights, patients are asked to complete a linear questionnaire (VAS) concerning well-being, odour, perspiration and wrinkling. In addition, the patients are examined daily while still fasting, for skin redness, skin moisture, skin elasticity and skin blood circulation in the parasacral region.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Spinal Cord Injury Pressure Ulcer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

new bedsheet

new bedsheet

Group Type EXPERIMENTAL

new bedsheet

Intervention Type DEVICE

sleeping 5 nights on the new bedsheet

conventional bedsheet

conventional bedsheet

Group Type PLACEBO_COMPARATOR

conventional bedsheet

Intervention Type DEVICE

sleeping 5 nights on the conventional bedsheet

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

new bedsheet

sleeping 5 nights on the new bedsheet

Intervention Type DEVICE

conventional bedsheet

sleeping 5 nights on the conventional bedsheet

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

specially developed low-friction hospital bed sheet normal hospital bedsheet

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* SCI patients without a presser ulcer for the last 2 months
* Paraplegic and tetraplegic patients
* complete and incomplete lesion (AIS A, AIS B, AIS C, AIS D)
* caused by illness or traumatic event
* smoker and non-smoker

Exclusion Criteria

* progressive disease
* severe accessory symptoms (diabetes mellitus, coronary heart disease, severe renal failure)
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Swiss Federal Laboratories for Material Sciences and Technology

UNKNOWN

Sponsor Role collaborator

Swiss Paraplegic Research, Nottwil

NETWORK

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Anke Scheel, MD

Role: PRINCIPAL_INVESTIGATOR

Swiss Paraplegic Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Swiss Paraplegic-Centre

Nottwil, Canton of Lucerne, Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Related Links

Access external resources that provide additional context or updates about the study.

http://www.paraplegie.ch

Swiss Paraplegic Centre Nottwil

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2010-04

Identifier Type: -

Identifier Source: org_study_id